The peripheral cannabinoid receptor knockout mice: an update

被引:100
作者
Buckley, N. E. [1 ]
机构
[1] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA
关键词
cB(2)R; CB2R-/-; mice; antifibrogenic; pain; allergic dermatitis; atherosclerosis; chemotaxis; osteoporosis; multiple sclerosis;
D O I
10.1038/sj.bjp.0707527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review gives an overview of the CB2 receptor (CB2R) knockout (CB2R-/-) mice phenotype and the work that has been carried out using this mutant mouse. Using the CB2R-/- mice, investigators have discovered the involvement of CB2R on immune cell function and development, infection, embryonic development, bone loss, liver disorders, pain, autoimmune inflammation, allergic dermatitis, atherosclerosis, apoptosis and chemotaxis. Using the CB2R-/- mice, investigators have also found that this receptor is not involved in cannabinoid-induced hypotension. In addition, the CB2R-/- mice have been used to determine specific tissue CB2R expression. The specificity of synthetic cannabinoid agonists, antagonists and anti-CB2R antibodies has been screened using tissues from CB2R-/- mice. Thus, the use of this mouse model has greatly helped reveal the diverse events involving the CB2R, and has aided in drug and antibody screening.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 92 条
[61]   Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors [J].
Pryce, G. ;
Baker, D. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) :519-525
[62]  
RABORN ES, 2007, J NEUROIMMUNE PHARM
[63]   Cannabinoid-mediated elevation of intracellular calcium: A structure-activity relationship [J].
Rao, GK ;
Kaminski, NE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02) :820-829
[64]   CYTOTOXICITY OF OXIDIZED LOW-DENSITY-LIPOPROTEIN TO MOUSE PERITONEAL-MACROPHAGES - AN ULTRASTRUCTURAL-STUDY [J].
REID, VC ;
MITCHINSON, MJ ;
SKEPPER, JN .
JOURNAL OF PATHOLOGY, 1993, 171 (04) :321-328
[65]  
Rickard DJ, 1996, J BONE MINER RES, V11, P312
[66]   Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor γ independently of cannabinoid receptors 1 and 2 [J].
Rockwell, Cheryl E. ;
Snider, Natasha T. ;
Thompson, Jerry T. ;
Heuvel, John P. Vanden ;
Kaminski, Norbert E. .
MOLECULAR PHARMACOLOGY, 2006, 70 (01) :101-111
[67]   Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception [J].
Ross, RA ;
Coutts, AA ;
McFarlane, SM ;
Anavi-Goffer, S ;
Irving, AJ ;
Pertwee, RG ;
MacEwan, DJ ;
Scott, RH .
NEUROPHARMACOLOGY, 2001, 40 (02) :221-232
[68]   Comparative biology of the endocannabinoid system - Possible role in the immune response [J].
Salzet, M ;
Breton, C ;
Bisogno, T ;
Di Marzo, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (16) :4917-4927
[69]   Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system [J].
Schatz, AR ;
Lee, M ;
Condie, RB ;
Pulaski, JT ;
Kaminski, NE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 142 (02) :278-287
[70]   Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A [J].
Shire, D ;
Calandra, B ;
Delpech, M ;
Dumont, X ;
Kaghad, M ;
LeFur, G ;
Caput, D ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) :6941-6946